文献速递治疗药物监测与药物基因组学特殊人群用药

静脉-静脉体外膜氧合期间氨苄西林的药代动力学:一例报告

Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report.
PubMed 文献 · Pharmacotherapy · 2023-06-08

该病例报告纳入两名接受静脉-静脉体外膜氧合(VV-ECMO)且合并粪肠球菌血流感染的患者,测定氨苄西林血清浓度并用一室开放模型计算药代动力学参数。患者A和B的氨苄西林谷浓度分别为5.87和39.2 mg/L,浓度在100%给药间隔内高于最低抑菌浓度(MIC)。结果提示ECMO患者可获得氨苄西林治疗浓度,治疗药物监测可用于确保达标。

要点

  • VV-ECMO合并粪肠球菌血流感染患者中,氨苄西林谷浓度可达5.87和39.2 mg/L。
  • 两例患者氨苄西林浓度在100%给药间隔内均高于MIC。
  • 治疗药物监测可用于确保ECMO患者氨苄西林血清浓度达标。

核心结论

  • 病例报告显示接受VV-ECMO的患者可获得氨苄西林治疗浓度,且治疗药物监测可用于确保血清浓度达标。

研究设计与样本

  • 病例报告,纳入两名接受静脉-静脉体外膜氧合(VV-ECMO)且合并粪肠球菌血流感染的患者,测定氨苄西林血清浓度。
  • 药代动力学参数采用一室开放模型计算。

主要发现

  • 患者A和患者B的氨苄西林谷浓度分别为5.87 mg/L和39.2 mg/L。
  • 基于上述结果,氨苄西林浓度在100%的给药间隔内高于最低抑菌浓度(MIC)。

关键数值与推荐

  • 氨苄西林谷浓度:患者A为5.87 mg/L,患者B为39.2 mg/L。
  • 氨苄西林浓度高于MIC的时间覆盖为100%给药间隔。

临床怎么用

  • 对接受VV-ECMO并使用氨苄西林治疗粪肠球菌感染的患者,可开展治疗药物监测以确保血清浓度达标。

局限性

  • 本文为仅含两例患者的病例报告,样本量小,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The presence of extracorporeal membrane oxygenation (ECMO) in addition to underlying critical illness can affect the pharmacokinetics and pharmacodynamics of drugs that are often required to treat this patient population. While ampicillin is the preferred agent for the treatment of susceptible Enterococcus faecalis infections, there are no in vivo pharmacokinetic studies regarding ampicillin dosing in patients receiving ECMO. This case report consists of two patients on venovenous ECMO with E. faecalis bloodstream infections in which ampicillin serum concentrations were measured. Pharmacokinetic parameters were calculated using a one compartment open model. Ampicillin trough levels were 5.87 and 39.2 mg/L for patients A and B, respectively. Based on these results, ampicillin concentrations were found to be above the minimum inhibitory concentration (MIC) for 100% of the dosing interval. The findings of this case report demonstrate that therapeutic concentrations of ampicillin can be obtained in patients on ECMO and therapeutic drug monitoring can be utilized to ensure adequate serum concentrations are achieved.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Kim S, Stucky NL, Drummond W, et al. Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report. Pharmacotherapy. 2023. PMID: 37243488. doi:10.1002/phar.2832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。